EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Lamina dura thickening in patients on antiresorptive therapy as a radiographic risk indicator of medication-related osteonecrosis of the jaw: a retrospective longitudinal cohort study

Sonya Radi iD, Samy El Bachaoui, Ilya Tsiklin, Constanza Pastenes, Hanne De Backer, Ruxandra Coropciuc, Tim Van den Wyngaert, Benoit Beuselinck, Reinhilde Jacobs iD

Dentomaxillofacial Radiology · 2026

DOI: 10.1093/dmfr/twag029 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Dentomaxillofacial Radiology, 2026. Verfasst von Sonya Radi und 8 weiteren Autor:innen. Beteiligte Einrichtung: OMFS-IMPATH Research Group, Department of Imaging and Pathology, Faculty of Medicine, KU Leuven, 3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Radiography, Panoramic, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation of Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study investigated whether antiresorptive drug (ARD) therapy is associated with lamina dura (LD) thickening, defined as a radiographic increase in the thickness of the normally thin, radiopaque cortical line surrounding the tooth root. It further evaluated whether LD thickening serves as a radiographic marker and risk indicator for medication-related osteonecrosis of the jaw (MRONJ).

Methods

Panoramic radiographs from 65 ARD-treated patients (University Hospital Leuven) and 65 age- and sex-matched controls were analyzed. Inclusion criteria were prior oncological diagnosis, high-dose intravenous ARD, and radiographs before and after therapy. Three blinded oral and maxillofacial radiologists categorized LD appearance into 4 grades: (0) not/barely visible, (1) normal, (2) mild thickening, and (3) marked thickening. Group differences and longitudinal changes were evaluated using appropriate non-parametric and time-to-event analyses.

Results

Among 130 participants, LD thickness remained stable in controls but increased in ARD-treated patients (P < .001). Within the ARD group, LD thickening changed over time (P < .001): 30.6% showed no change, 55.4% developed mild thickening, and 13.8% marked thickening. Controls showed minimal change (P = .011), with 9.2% developing mild thickening. Kaplan-Meier analysis estimated a median time to LD thickening of 27 months, with a higher thickening probability in ARD-treated patients than controls (P < .001). Lamina dura thickening was not directly associated with MRONJ (P = .39).

Conclusion

Lamina dura thickening is strongly associated with long-term ARD exposure and shows progressive changes. Although not directly associated with MRONJ in this cohort, it may still represent a potential risk indicator, warranting confirmation in further studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiography, PanoramicBisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsHumansFemaleRetrospective StudiesLongitudinal StudiesMaleAgedRisk FactorsAged, 80 and overCase-Control StudiesMiddle Aged

Stichwörter der Autor:innen

MRONJantiresorptive drugslamina durapanoramic radiography

Substanzen

Bone Density Conservation Agents

Autor:innen und Institutionen

  • OMFS-IMPATH Research Group, Department of Imaging and Pathology, Faculty of Medicine, KU Leuven, 3000 Leuven, Belgium.
  • Department of Oral and Maxillofacial Surgery, University Hospital of Leuven, 3000 Leuven, Belgium.
  • Oral and Maxillofacial Radiology Department, Faculty of Dentistry, Universidad de Los Andes, 7620157 Santiago, Chile.
  • Department of Nuclear Medicine, University Hospital of Antwerp, 2610 Wilrijk, Antwerp, Belgium.
  • Laboratory of Experimental Oncology, KU Leuven, 3000 Leuven, Belgium.
  • University Hospitals Leuven, Medical Oncology, 3000 Leuven, Belgium.

ORCID-Profile: Sonya Radi, Reinhilde Jacobs

Förderung

  • Research Foundation of Flanders

Zitieren

APA

Radi, S., El Bachaoui, S., Tsiklin, I., Pastenes, C., De Backer, H., Coropciuc, R., Van den Wyngaert, T., Beuselinck, B., & Jacobs, R. (2026). Lamina dura thickening in patients on antiresorptive therapy as a radiographic risk indicator of medication-related osteonecrosis of the jaw: a retrospective longitudinal cohort study. Dentomaxillofacial Radiology. https://doi.org/10.1093/dmfr/twag029

Vancouver

Radi S, El Bachaoui S, Tsiklin I, Pastenes C, De Backer H, Coropciuc R, et al. Lamina dura thickening in patients on antiresorptive therapy as a radiographic risk indicator of medication-related osteonecrosis of the jaw: a retrospective longitudinal cohort study. Dentomaxillofacial Radiology. 2026. doi:10.1093/dmfr/twag029

BibTeX
@article{Radi2026,
  author = {Radi, Sonya and El Bachaoui, Samy and Tsiklin, Ilya and Pastenes, Constanza and De Backer, Hanne and Coropciuc, Ruxandra and Van den Wyngaert, Tim and Beuselinck, Benoit and Jacobs, Reinhilde},
  title = {Lamina dura thickening in patients on antiresorptive therapy as a radiographic risk indicator of medication-related osteonecrosis of the jaw: a retrospective longitudinal cohort study},
  journal = {Dentomaxillofacial Radiology},
  year = {2026},
  doi = {10.1093/dmfr/twag029}
}
Kostenlos starten →